This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Why Not a Cure?

David L. Epstein, MD

Arch Ophthalmol. 1987;105(9):1187-1188.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

As one entering his second decade in the care of glaucoma patients, and as one involved in glaucoma research, it seems a reasonable time to ask how effective our therapeutic approaches are. Glaucoma is somewhat unique in ophthalmic diseases with its chronic, relentless course and its customary need for truly unending medical therapies that, in fact, do not reverse the process, are difficult to administer, and may have significant morbidity. Perhaps only uveitis is a more discouraging disease, but even here there is always a chance, at least, for a remission. "Do I really have to use this medication the rest of my life?" the glaucoma patient asks. Unfortunately, the answer is usually yes, for although glaucoma may sometimes "burn out" in old age, it is also often the augury for the decline in other vital functions as well.

Wise senior clinicians have pointed out that it is only in . . . [Full Text PDF of this Article]

Author Affiliations
Boston

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?